These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
245 related articles for article (PubMed ID: 20196731)
1. Circulating nucleic acids as a potential source for cancer biomarkers. Vlassov VV; Laktionov PP; Rykova EY Curr Mol Med; 2010 Mar; 10(2):142-65. PubMed ID: 20196731 [TBL] [Abstract][Full Text] [Related]
2. Circulating nucleic acids in plasma or serum (CNAPS) as prognostic and predictive markers in patients with solid neoplasias. Goebel G; Zitt M; Zitt M; Müller HM Dis Markers; 2005; 21(3):105-20. PubMed ID: 16276004 [TBL] [Abstract][Full Text] [Related]
3. Circulating nucleic acids as a tumor marker. Chan KC; Lo YM Histol Histopathol; 2002; 17(3):937-43. PubMed ID: 12168805 [TBL] [Abstract][Full Text] [Related]
4. Circulating nucleic acids in plasma or serum. Anker P; Lyautey J; Lederrey C; Stroun M Clin Chim Acta; 2001 Nov; 313(1-2):143-6. PubMed ID: 11694252 [TBL] [Abstract][Full Text] [Related]
5. Circulating cell-free nucleic acids as biomarkers in colorectal cancer screening and diagnosis. Tóth K; Barták BK; Tulassay Z; Molnár B Expert Rev Mol Diagn; 2016; 16(2):239-52. PubMed ID: 26652067 [TBL] [Abstract][Full Text] [Related]
6. Diagnostic potential of circulating nucleic acids for oncology. Goessl C Expert Rev Mol Diagn; 2003 Jul; 3(4):431-42. PubMed ID: 12877383 [TBL] [Abstract][Full Text] [Related]
8. Relevance of circulating tumor cells, extracellular nucleic acids, and exosomes in breast cancer. Friel AM; Corcoran C; Crown J; O'Driscoll L Breast Cancer Res Treat; 2010 Oct; 123(3):613-25. PubMed ID: 20549336 [TBL] [Abstract][Full Text] [Related]
9. Circulating tumor markers: harmonizing the yin and yang of CTCs and ctDNA for precision medicine. Batth IS; Mitra A; Manier S; Ghobrial IM; Menter D; Kopetz S; Li S Ann Oncol; 2017 Mar; 28(3):468-477. PubMed ID: 27998963 [TBL] [Abstract][Full Text] [Related]
10. Liquid Profiling of Circulating Nucleic Acids as a Novel Tool for the Management of Cancer Patients. Holdenrieder S Adv Exp Med Biol; 2016; 924():53-60. PubMed ID: 27753019 [TBL] [Abstract][Full Text] [Related]
15. Circulating nucleic acids and proteomics of plasma/serum: clinical utility. Taback B; Hoon DS Ann N Y Acad Sci; 2004 Jun; 1022():1-8. PubMed ID: 15251932 [TBL] [Abstract][Full Text] [Related]
16. Plasma nucleic acids in the diagnosis and management of malignant disease. Johnson PJ; Lo YM Clin Chem; 2002 Aug; 48(8):1186-93. PubMed ID: 12142371 [TBL] [Abstract][Full Text] [Related]
17. Circulating nucleic acids in plasma and serum (CNAPS) and its relation to stem cells and cancer metastasis: state of the issue. García-Olmo DC; Ruiz-Piqueras R; García-Olmo D Histol Histopathol; 2004 Apr; 19(2):575-83. PubMed ID: 15024717 [TBL] [Abstract][Full Text] [Related]
18. Circulating nucleic acids (CNAs) and cancer--a survey. Fleischhacker M; Schmidt B Biochim Biophys Acta; 2007 Jan; 1775(1):181-232. PubMed ID: 17137717 [TBL] [Abstract][Full Text] [Related]
19. New markers for cancer detection. Wong IH; Lo YM Curr Oncol Rep; 2002 Nov; 4(6):471-7. PubMed ID: 12354358 [TBL] [Abstract][Full Text] [Related]
20. The role of circulating tumour cells and nucleic acids in blood for the detection of bladder cancer: A systematic review. Khetrapal P; Lee MWL; Tan WS; Dong L; de Winter P; Feber A; Kelly JD Cancer Treat Rev; 2018 May; 66():56-63. PubMed ID: 29684744 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]